Minneapolis, MN, United States of America

Brenda Kay Schultz

This inventor holds 2 USPTO granted patents. Top assignee: Medtronic, Inc.. Active years: 1999-2005.


% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 2

Forward Citations = 280(Granted Patents)


Company Filing History:


Years Active: 1999-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brenda Kay Schultz: Innovator in Drug Delivery Systems

Introduction

Brenda Kay Schultz is a notable inventor based in Minneapolis, MN (US). She has made significant contributions to the field of drug delivery systems, holding 2 patents that enhance the efficacy and safety of medication administration.

Latest Patents

One of her latest patents is titled "Decision information system for drug delivery devices." This invention encompasses systems, methods, and computer programs designed to improve decision-making when using multiple drugs in drug delivery devices, including implantable devices. The program calculates consistent drug mixture amounts and flow rates based on user inputs, allowing for precise drug administration as per physician instructions. Another significant patent is for a "Filtered intracerebroventricular or intraspinal access port with direct." This invention features a filter assembly along the fluid flow path, ensuring that medication administered through a surgically implanted catheter is properly filtered before reaching the patient.

Career Highlights

Brenda is currently employed at Medtronic, Inc., a leading company in medical technology. Her work focuses on developing innovative solutions that improve patient outcomes in drug delivery.

Collaborations

Throughout her career, Brenda has collaborated with talented professionals, including Eric E Buchser and Brian T Dummann, who have contributed to her projects and innovations.

Conclusion

Brenda Kay Schultz exemplifies the spirit of innovation in the medical field, particularly in drug delivery systems. Her patents reflect her commitment to enhancing patient care through technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…